Sri Data Plus: Pfizer buying spree continues with $5.4B hematology dealPfizer buying spree continues with $5.4B hematology dealPfizer buying spree continues with $5.4B hematology deal

Monday, August 8, 2022

Pfizer buying spree continues with $5.4B hematology dealPfizer buying spree continues with $5.4B hematology dealPfizer buying spree continues with $5.4B hematology deal

Pfizer buying spree continues with $5.4B hematology deal

The company plans to have about $25 billion in sales by 2030 come from new business developments.

from Section Page News - Modern Healthcare https://ift.tt/7hFnOpx

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)